Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-04

Clinical Trial Update: Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating the effects of naltrexone in nonsuicidal self-injury; the study status is not yet recruiting and is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nonsuicidal Self-Injury | Phase 2 | Status: NOT_YET_RECRUITING